Synonym: N-(14-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6,9,12-tetraoxatetradecan-1-yl)-4′-fluoro-3′-methyl-2-[4-(4-methyl-1H-imidazol-5-yl)piperidin-1-yl]-[1,1′-biphenyl]-4-carboxamide
Empirical Formula (Hill Notation): C46H54FN7O9
Molecular Weight: 867.96
Linear Formula: C46H54FN7O9
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| Quality Level |
100  |
| SMILES string |
O=C(CCC1N2C(C(C=CC=C3NCCOCCOCCOCCOCCNC(C4=CC(N5CCC(C6=C(C)N=CN6)CC5)=C(C7=CC=C(F)C(C)=C7)C=C4)=O)=C3C2=O)=O)NC1=O |
| solubility |
DMSO: 2 mg/mL, clear |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
d9A-2 is a potent degrader (PROTAC) of the solute carrier SLC9A1 impairs recovery from acid load and is potently cytotoxic to multiple cancer cell lines. Also, d9A-2 incites degradation of some SLC9 members including closely related SLC9A2 and SLC9A4, distant SLC9A7 and SLC9B1. d9A-2 comprise w9A ligand binding to SLC9A1 and the phthalimide-based CRBN binder. |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |
